Corcept Therapeutics Incorporated (CORT): Price and Financial Metrics

CORT POWR Grades

• Quality is the dimension where CORT ranks best; there it ranks ahead of 99.85% of US stocks.
• The strongest trend for CORT is in Sentiment, which has been heading down over the past 179 days.
• CORT ranks lowest in Growth; there it ranks in the 7th percentile.

CORT Stock Summary

• For CORT, its debt to operating expenses ratio is greater than that reported by merely 3.86% of US equities we're observing.
• Equity multiplier, or assets relative to shareholders' equity, comes in at 1.15 for CORCEPT THERAPEUTICS INC; that's greater than it is for merely 11.16% of US stocks.
• With a year-over-year growth in debt of -79.58%, CORCEPT THERAPEUTICS INC's debt growth rate surpasses just 2.36% of about US stocks.
• Stocks with similar financial metrics, market capitalization, and price volatility to CORCEPT THERAPEUTICS INC are ALRM, HLIT, AGYS, FORM, and MNTS.
• CORT's SEC filings can be seen here. And to visit CORCEPT THERAPEUTICS INC's official web site, go to www.corcept.com.

CORT Valuation Summary

• CORT's price/sales ratio is 6.2; this is 21.57% higher than that of the median Healthcare stock.
• CORT's EV/EBIT ratio has moved up 50.3 over the prior 233 months.

Below are key valuation metrics over time for CORT.

CORT Growth Metrics

The 5 year cash and equivalents growth rate now stands at 122.45%.
• Its year over year net cashflow from operations growth rate is now at 23.31%.
• Its 4 year net cashflow from operations growth rate is now at 490.98%.

The table below shows CORT's growth in key financial areas (numbers in millions of US dollars).

CORT's Quality Factors

• CORT has a Quality Grade of A, ranking ahead of 98.86% of graded US stocks.
• CORT's asset turnover comes in at 0.616 -- ranking 52nd of 681 Pharmaceutical Products stocks.
• OTIC, ABT, and AVDL are the stocks whose asset turnover ratios are most correlated with CORT.

The table below shows CORT's key quality metrics over time.